Tumor regression by the anti-4-1BB/anti-CD73 combination therapy was associated with enhanced infiltration of competent IFN-γ+CD8+ T cells while reduced Treg accumulation, which led to a shift in the balance of effector T cells to Treg cells in the tumors. Here, IFNG is linked to neoplasm.